Rekah
| Primary URL | Location | Industry | rekah[.]co[.]il |
Country
Israel
|
Pharmaceuticals
|
|---|
Profile
Rekah isan Israeli pharmaceutical company that operates under the alias Rekah. The firm focuses on the distribution of medicinal products within the Israeli healthcare market. Its activities involve ensuring that pharmaceutical supplies reach hospitals, pharmacies, and other healthcare providers. The company maintains a dedicated distribution network to support its product delivery. Rekah’s headquarters are situated in Israel, anchoring its operations to the national market.
The available sources do not provide explicit figures regarding Rekah’s workforce size, annual revenue, or market share. Consequently, no quantitative scale metrics can be stated with confidence from the given information. What is clear is that the company functions as a pharmaceutical distributor operating within Israel’s domestic market.
In June 2024, Rekah was the target of a cyber attack that specifically aimed at its distribution system. Unauthorized access to subsidiary systems was detected, triggering an immediate response. The company proactively disabled the compromised components of its distribution infrastructure to limit further exposure. Rekah convened an internal response team and enlisted external cybersecurity experts to contain the breach, conduct investigations, and restore operations. Preliminary assessments indicated that the damage was limited and that production systems remained unaffected throughout the incident. To mitigate the disruption caused by the halted automated distribution, the organization explored temporary manual distribution methods while noting that existing customer inventories likely prevented immediate supply shortages.
No details concerning Rekah’s ownership structure, parent company, or subsidiary relationships are disclosed in the provided material. Therefore, any description of its corporate hierarchy would be speculative and is omitted.
The June 2024 incident highlights Rekah’s reliance on secure distribution channels and its capacity to engage specialized expertise during a cybersecurity event. Based on the confirmed facts, Rekah remains identified as an Israeli pharmaceutical distributor that encountered a notable cyber incident in mid‑2024.